OAKLAND, Calif.–Riffyn, a global provider of cloud software for scientific process design and data analytics, announced today that Natalie White, a leader in biopharma IT, has joined Riffyn’s executive team as the company’s Executive Director of Business Development. White previously held senior roles in strategy and operations at Thermo Fisher Scientific and Core Informatics. She […]
Livermore, CA, and Boston, MA, USA: A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to increase their activities. “In the past decade, genomics and […]
BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced that it has formed a new data partnership with the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus that will incorporate clinical and genomic-consented records and biobank samples representing an ethnically diverse patient population […]
Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader Company demonstrates solidity of its business model with banks joining in the […]
FDA’s Office of Pharmaceutical Quality adds new licenses of Simcyp™ Simulator PRINCETON, N.J.— Certara, a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has again renewed and expanded its licenses of Certara’s biosimulation software, with more than 400 user licenses of Simcyp™ and Phoenix™ platforms. Eleven divisions and offices of […]
Company’s Informatics Solutions Meet AICPA’s Trust Service Principles for Security, Confidentiality & Availability WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that the PerkinElmer Signals™ Notebook and PerkinElmer Signals™ Medical Review SaaS solutions have been granted SOC 2 Level 1 Attestation for the American Institute of […]
Improvements Establish HTPK Simulation Module as Key Gateway for Lead Compound Selection Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has entered into an accelerated second phase of its collaboration with a large pharmaceutical company to tailor […]
Sartorius acquires shareholding in DFKI Machine learning systems for life science applications Extension of the joint Sartorius AI Lab (SAIL) KAISERSLAUTERN and GÖTTINGEN, Germany — Sartorius has joined the group of shareholders of the German Research Center for Artificial Intelligence (DFKI). The Göttingen-based life science group and DFKI have already been working together for some time in […]
Industry-leading enterprise software for leveraging translational and clinical research simplifies data ingestion and access and extends analytical options for users Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of Genedata Profiler® 15.0, the latest version of its enterprise software that makes translational and clinical research data […]
An open-science collaboration between Riffyn, Imperial College’s Centre for Synthetic Biology (IC-CSynB), and SynbiCITE’s London Biofoundry sets the standard for a digital backbone for synthetic biology research and education in scientific reproducibility. Riffyn Inc. and Imperial College today announce a public/private partnership to bring Riffyn’s process data system, Riffyn Nexus, to the public synthetic biology […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
